ZVSA

ZyVersa Therapeutics, Inc.

Healthcare · Biotechnology

$0.31Jul 15, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

ZyVersa Therapeutics, Inc. execution reads as mixed on proprietary earnings and initiative evidence.

ExecutionMixed

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

ZVSA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ZVSA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for ZyVersa Therapeutics, Inc. (ZVSA) — events, not interpretation.

Event
Last session July 15, 2026 at $0.31.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

ZyVersa Therapeutics, Inc. (ZVSA)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for ZyVersa Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$2.52M

ZVSA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow ZyVersa Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.